Back to SYRE

CHARLES SCHWAB INVESTMENT MANAGEMENT INC → SYRE

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$90.5M
Q3 2026
Peak value
$90.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$18.8M
Q1 2026$28.4M
Q2 2026$58M
Q3 2026$90.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$90.5M1.02M——
Q2 2026$58M653.0K——
Q1 2026$28.4M562.7K——
Q4 2025$18.8M574.6K——

Other funds holding SYRE

Other CHARLES SCHWAB INVESTMENT MANAGEMENT INC positions

NVDA

NVIDIA CORPORATION

$38.2B
AAPL

APPLE INC

$34.9B
NVDA

NVIDIA CORPORATION

$32.1B
AAPL

APPLE INC

$29.3B
NVDA

NVIDIA CORPORATION

$29.1B
NVDA

NVIDIA CORPORATION

$28B
MSFT

MICROSOFT CORP

$28B
AAPL

APPLE INC

$27.1B
CHARLES SCHWAB INVESTMENT MANAGEMENT INC SYRE Holdings: 13F Position History | Track13F